Multidrug-Resistant Klebsiella pneumoniae Strains in a Hospital: Phylogenetic Analysis to Investigate Local Epidemiology
- PMID: 39770744
- PMCID: PMC11677512
- DOI: 10.3390/microorganisms12122541
Multidrug-Resistant Klebsiella pneumoniae Strains in a Hospital: Phylogenetic Analysis to Investigate Local Epidemiology
Abstract
Multidrug-resistant Klebsiella pneumoniae is a significant healthcare challenge that particularly affects vulnerable patients through opportunistic nosocomial infections. Surveillance is crucial for monitoring the prevalence of these infections. Eighty-four KPC K. pneumoniae strains (2019-2022) were collected from patients admitted in Fondazione Policlinico Universitario Campus Bio-Medico. Strains were identified by MALDI-TOF and tested for antimicrobial susceptibility, and gene amplification was performed to identify the different blaKPC variants. Phylogenetic reconstructions were carried out using Bayesian methods. Additionally, to create a Bayesian skyline plot (BSP), additional analyses were conducted, running a simulation of 100 million generations under a Bayesian skyline model along with the uncorrelated log-normal relaxed clock model. To identify potential subgroups within genetic clusters and evaluate genetic variability among sequences, principal coordinate analysis (PCoA) was performed. In total, 84 Klebsiella pneumoniae isolates were classified as multidrug-resistant (MDR), characterized by resistance to three or more antibiotic classes, including carbapenems, and testing positive for KPC gene presence, and were included in the study. The Bayesian evolutionary tree for K. pneumoniae showed strongly supported branches but no genetic structure related to sampling dates or hospital departments. Phylogenetic analysis revealing a 73-year evolutionary span of K. pneumoniae strains. PCoA analysis identified three genetic outliers from 2022 and one from 2021, indicating higher genetic distances. The Bayesian skyline plot revealed increased genetic variability peaking at the end of 2019, followed by stabilization from early 2020 onward, with no significant changes in genetic variability thereafter. Overall, the study found no genetic structure correlating with sampling date or hospital department, suggesting significant variability in pathogen introduction during the pandemic. The increase in multidrug-resistant K. pneumoniae was linked to the influx of severe COVID-19 cases, prolonged hospitalizations, and heightened broad-spectrum antibiotic use, which likely facilitated resistance development and transmission amidst altered infection control practices.
Keywords: Klebsiella pneumoniae; MDR; epidemiology investigation; phylogenetic analysis.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Exploring the resistome, virulome, and mobilome of multidrug-resistant Klebsiella pneumoniae isolates: deciphering the molecular basis of carbapenem resistance.BMC Genomics. 2024 Apr 25;25(1):408. doi: 10.1186/s12864-024-10139-y. BMC Genomics. 2024. PMID: 38664636 Free PMC article.
-
Exploring multidrug-resistant Klebsiella pneumoniae antimicrobial resistance mechanisms through whole genome sequencing analysis.BMC Microbiol. 2023 Sep 2;23(1):245. doi: 10.1186/s12866-023-02974-y. BMC Microbiol. 2023. PMID: 37660028 Free PMC article.
-
MALDI-TOF mass spectrometry and blakpc gene phylogenetic analysis of an outbreak of carbapenem-resistant K. pneumoniae strains.New Microbiol. 2015 Oct;38(4):541-50. Epub 2015 Oct 20. New Microbiol. 2015. PMID: 26485012
-
Genetic and Phenotypic Characterization of Multidrug-Resistant Klebsiella pneumoniae from Liver Abscess.Microbiol Spectr. 2023 Feb 14;11(1):e0224022. doi: 10.1128/spectrum.02240-22. Epub 2023 Jan 4. Microbiol Spectr. 2023. PMID: 36598251 Free PMC article.
-
Genome sequencing unveils blaKPC-2-harboring plasmids as drivers of enhanced resistance and virulence in nosocomial Klebsiella pneumoniae.mSystems. 2024 Feb 20;9(2):e0092423. doi: 10.1128/msystems.00924-23. Epub 2024 Jan 9. mSystems. 2024. PMID: 38193706 Free PMC article.
Cited by
-
Lessons from Four Years (2021-2024) of Klebsiella Pneumoniae Resistance Surveillance Epidemiological Trends in a Romanian Intensive Care Unit.Antibiotics (Basel). 2025 Aug 12;14(8):825. doi: 10.3390/antibiotics14080825. Antibiotics (Basel). 2025. PMID: 40868018 Free PMC article.
-
Diagnosis and treatment of Aspergillus terreus and Klebsiella pneumoniae coinfection following myocardial infarction: A case report and literature review.IDCases. 2025 Jun 21;41:e02301. doi: 10.1016/j.idcr.2025.e02301. eCollection 2025. IDCases. 2025. PMID: 40641905 Free PMC article.
References
-
- OECD-WHO Briefing Paper on Infection Prevention and Control: Addressing the Burden of Infections and Antimicrobial Resistance Associated with Health Care. Focus on G7 Countries. 2022. [(accessed on 18 October 2022)]. Available online: https://www.oecd.org/content/dam/oecd/en/topics/policy-sub-issues/antimi....
-
- Cogliati Dezza F., Arcari G., Alessi F., Valeri S., Curtolo A., Sacco F., Ceccarelli G., Raponi G., Alessandri F., Mastroianni C.M., et al. Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics Compared. Antibiotics. 2022;11:926. doi: 10.3390/antibiotics11070926. - DOI - PMC - PubMed
-
- Falcone M., Tiseo G., Arcari G., Leonildi A., Giordano C., Tempini S., Bibbolino G., Mozzo R., Barnini S., Carattoli A., et al. Spread of Hypervirulent Multidrug-Resistant ST147 Klebsiella pneumoniae in Patients with Severe COVID-19: An Observational Study from Italy, 2020–2021. J. Antimicrob. Chemother. 2022;77:1140–1145. doi: 10.1093/jac/dkab495. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources